Morgan Stanley Oragenics Inc Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $15.59 $0 - $140	9 New	9 $0
Q2 2022 Oct 27, 2022	SELL	$0.24 - $0.42 $23 - $41	-99 Reduced 98.02%	2 $0
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.42 $23 - $41	-99 Reduced 98.02%	2 $0
Q1 2022 Oct 27, 2022	BUY	$0.33 - $0.56 $32 - $55	99 Added 4950.0%	101 $0
Q1 2022 May 13, 2022	BUY	$0.33 - $0.56 $32 - $54	98 Added 3266.67%	101 $0
Q4 2021 Feb 14, 2022	BUY	$0.43 - $0.69 $1 - $2	3 New	3 $0

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.